Minerva Surgical, a women’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), closed its IPO of 6.25 million shares at a public offering price of $12 per share. The aggregate gross proceeds to Minerva Surgical from the offering were $75 million. Read more.
Related Posts
Validic Hauls in $12M
Kaiser Permanente Ventures led, and was joined by Arkin Digital Health, Green Park and Golf Ventures, Ziegler, Gore Range Capital, Greycroft Partners and SJF Ventures.
November 23, 2022
AI Healthcare Firm Aidoc Raises $110M
The round was co-led by global growth investors TCV and Alpha Intelligence Capital.
June 21, 2022
Hicuity Health Completes Growth Financing Round
Concord Health Partners led the round. The amount was not disclosed.
June 28, 2023
Options MD Raises $2.35M to Expand Virtual Care for Severe Depression
Bread & Butter Ventures led, with participation from M13, Bright Ventures and Collab Capital alongside returning investors MedMountain Ventures and Techstars.
November 2, 2022